EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reliability and validity of cough peak flow measurements in myasthenia gravis

Ryota Kuroiwa, Kazumoto Shibuya, Takeshi Inagaki, Takeru Nara, Marie Nemoto, Yuka Doi, Manato Yasuda, Akiyuki Uzawa, Yuki Shiko, Atsushi Murata, Yoshitaka Yamanaka, Satoshi Kuwabara

Neuromuscular Disorders · 2024-08 · 41 · 29-34

DOI: 10.1016/j.nmd.2024.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuromuscular Disorders, 2024-08. Verfasst von Ryota Kuroiwa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rehabilitation Medicine, Chiba University Hospital, Chiba, Japan; Department of Neurology, Graduate School of Medicine, Chiba University,…. Hauptthemen laut MEDLINE: Myasthenia Gravis, Cough. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Decreased cough strength in myasthenia gravis (MG) leads to aspiration and increases the risk of MG crisis. The aim of this study was to clarify the reliability and validity of cough peak flow (CPF) measurements in MG. A total of 26 patients with MG who underwent CPF measurements using the peak flow meter by themselves were included. MG symptoms were evaluated by pulmonary function tests and clinical MG assessment scales before and after immune-treatments. The relationship between CPF and pulmonary function tests and MG comprehensive were assessed. The cut-off value of CPF for aspiration risk was determined and the area under the curve (AUC) was calculated. The intraclass correlation coefficient was more than 0.95 for pre-and post-treatment. Positive correlations were found between CPF and almost all spirometric values as well as between the differences of pre-and post-treatment in CPF and quantitative myasthenia gravis score. The CPF for identifying the aspiration risk was used to calculate the CPF cut-off value of 205 L/min with a sensitivity of 0.77, specificity of 0.90, and AUC of 0.85. The CPF, a convenient measure by patients themselves, has a high reliability in patients with MG, and is a useful biomarker reflecting MG symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisCoughHumansMaleFemaleMiddle AgedReproducibility of ResultsAdultAgedPeak Expiratory Flow RateRespiratory Function TestsSensitivity and Specificity

Stichwörter der Autor:innen

AspirationCough peak flowMyasthenia gravisReliabilityValidity

Autor:innen und Institutionen

  • Division of Rehabilitation Medicine, Chiba University Hospital, Chiba, Japan; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: pseudoarthrosis7@chiba-u.jp.
  • Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Division of Physical Therapy, Department of Rehabilitation, Faculty of Health Science, Chiba Prefectural University of Health Sciences, Chiba, Japan.
  • Division of Rehabilitation Medicine, Chiba University Hospital, Chiba, Japan; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Division of Rehabilitation Medicine, Chiba University Hospital, Chiba, Japan.
  • Department of Rehabilitation Therapy, Chiba Rehabilitation Center, Chiba, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kuroiwa, R., Shibuya, K., Inagaki, T., Nara, T., Nemoto, M., Doi, Y., Yasuda, M., Uzawa, A., Shiko, Y., Murata, A., Yamanaka, Y., & Kuwabara, S. (2024). Reliability and validity of cough peak flow measurements in myasthenia gravis. Neuromuscular Disorders, 41, 29-34. https://doi.org/10.1016/j.nmd.2024.06.003

Vancouver

Kuroiwa R, Shibuya K, Inagaki T, Nara T, Nemoto M, Doi Y, et al. Reliability and validity of cough peak flow measurements in myasthenia gravis. Neuromuscular Disorders. 2024;41:29-34. doi:10.1016/j.nmd.2024.06.003

BibTeX
@article{Kuroiwa2024,
  author = {Kuroiwa, Ryota and Shibuya, Kazumoto and Inagaki, Takeshi and Nara, Takeru and Nemoto, Marie and Doi, Yuka and Yasuda, Manato and Uzawa, Akiyuki and Shiko, Yuki and Murata, Atsushi and Yamanaka, Yoshitaka and Kuwabara, Satoshi},
  title = {Reliability and validity of cough peak flow measurements in myasthenia gravis},
  journal = {Neuromuscular Disorders},
  year = {2024},
  volume = {41},
  pages = {29--34},
  doi = {10.1016/j.nmd.2024.06.003}
}
Kostenlos starten →